Is your current medication not enough? If you are between the ages of 18 and 50, have been diagnosed with schizophrenia and feel that your current medication is not effective for your cognitive symptoms, please contact us.
Leading the way in personalized medicine. Pharmacogenomics examines links between genetics and treatment.
Clinical research into treatments for Major Depressive Disorder and it’s associated symptoms.
Spravato© is a prescription medicine, used with an antidepressant take by mouth, for Treatment Resistant Depression (TRD) in adults.
Transcranial Magnetic Stimulation is a non-invasive treatment for depression symptoms unresponsive to other treatments.
established in 2012, Chatham-Kent Clinical Trials Research Centre strives for excellence in patient care and professional practice.